EdgarLookup

TRAVELERS COMPANIES, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that TRAVELERS COMPANIES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
12.9%
Profit Margin
Net income ÷ revenue
4.4%
Return on Assets
Net income ÷ assets
3.37x
Debt-to-Equity
Total liabilities ÷ equity
+5.2%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $48.83B Feb 12, 2026
FY2025 Dec 31, 2024 $46.42B Feb 12, 2026
FY2025 Dec 31, 2023 $41.36B Feb 12, 2026
FY2024 Dec 31, 2022 $36.88B Feb 13, 2025
FY2023 Dec 31, 2021 $34.82B Feb 15, 2024
FY2020 Dec 31, 2020 $8.40B Feb 11, 2021
FY2020 Sep 30, 2020 $8.28B Feb 11, 2021
FY2020 Jun 30, 2020 $7.40B Feb 11, 2021
FY2020 Mar 31, 2020 $7.91B Feb 11, 2021
FY2020 Dec 31, 2019 $8.06B Feb 11, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.29B Feb 12, 2026
FY2025 Dec 31, 2024 $5.00B Feb 12, 2026
FY2025 Dec 31, 2023 $2.99B Feb 12, 2026
FY2024 Dec 31, 2022 $2.84B Feb 13, 2025
FY2023 Dec 31, 2021 $3.66B Feb 15, 2024
FY2020 Dec 31, 2020 $1.31B Feb 11, 2021
FY2020 Sep 30, 2020 $827.00M Feb 11, 2021
FY2020 Jun 30, 2020 ($40.00M) Feb 11, 2021
FY2020 Mar 31, 2020 $600.00M Feb 11, 2021
FY2020 Dec 31, 2019 $873.00M Feb 11, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2014 Dec 31, 2014 $3.64B Feb 12, 2015
FY2014 Dec 31, 2013 $3.57B Feb 12, 2015
FY2014 Dec 31, 2012 $2.44B Feb 12, 2015
FY2013 Dec 31, 2011 $1.39B Feb 13, 2014
FY2012 Dec 31, 2010 $3.04B Feb 19, 2013
FY2011 Dec 31, 2009 $3.60B Feb 16, 2012

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.12B Feb 12, 2026
FY2025 Dec 31, 2024 $5.82B Feb 12, 2026
FY2025 Dec 31, 2023 $5.18B Feb 12, 2026
FY2024 Dec 31, 2022 $4.81B Feb 13, 2025
FY2023 Dec 31, 2021 $4.68B Feb 15, 2024
FY2022 Dec 31, 2020 $4.51B Feb 16, 2023
FY2021 Dec 31, 2019 $4.37B Feb 17, 2022
FY2020 Dec 31, 2018 $4.30B Feb 11, 2021
FY2019 Dec 31, 2017 $4.17B Feb 13, 2020
FY2018 Dec 31, 2016 $4.15B Feb 14, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.61B Feb 12, 2026
FY2025 Dec 31, 2024 $9.07B Feb 12, 2026
FY2025 Dec 31, 2023 $7.71B Feb 12, 2026
FY2024 Dec 31, 2022 $6.47B Feb 13, 2025
FY2023 Dec 31, 2021 $7.27B Feb 15, 2024
FY2022 Dec 31, 2020 $6.52B Feb 16, 2023
FY2021 Dec 31, 2019 $5.21B Feb 17, 2022
FY2020 Dec 31, 2018 $4.38B Feb 11, 2021
FY2019 Dec 31, 2017 $4.15B Feb 13, 2020
FY2018 Dec 31, 2016 $4.47B Feb 14, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $143.71B Feb 12, 2026
FY2025 Dec 31, 2024 $133.19B Feb 12, 2026
FY2024 Dec 31, 2023 $125.98B Feb 13, 2025
FY2023 Dec 31, 2022 $115.72B Feb 15, 2024
FY2022 Dec 31, 2021 $120.47B Feb 16, 2023
FY2021 Dec 31, 2020 $116.76B Feb 17, 2022
FY2020 Dec 31, 2019 $110.12B Feb 11, 2021
FY2019 Dec 31, 2018 $104.23B Feb 13, 2020
FY2018 Dec 31, 2017 $103.48B Feb 14, 2019
FY2017 Dec 31, 2016 $100.25B Feb 15, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $110.81B Feb 12, 2026
FY2025 Dec 31, 2024 $105.33B Feb 12, 2026
FY2024 Dec 31, 2023 $101.06B Feb 13, 2025
FY2023 Dec 31, 2022 $94.16B Feb 15, 2024
FY2022 Dec 31, 2021 $91.58B Feb 16, 2023
FY2021 Dec 31, 2020 $87.56B Feb 17, 2022
FY2020 Dec 31, 2019 $84.18B Feb 11, 2021
FY2019 Dec 31, 2018 $81.34B Feb 13, 2020
FY2018 Dec 31, 2017 $79.75B Feb 14, 2019
FY2017 Dec 31, 2016 $77.02B Feb 15, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $32.89B Feb 12, 2026
FY2025 Dec 31, 2024 $27.86B Feb 12, 2026
FY2025 Dec 31, 2023 $24.92B Feb 12, 2026
FY2024 Dec 31, 2022 $21.56B Feb 13, 2025
FY2023 Dec 31, 2021 $28.89B Feb 15, 2024
FY2022 Dec 31, 2020 $29.20B Feb 16, 2023
FY2021 Dec 31, 2019 $25.94B Feb 17, 2022
FY2020 Dec 31, 2018 $22.89B Feb 11, 2021
FY2019 Dec 31, 2017 $23.73B Feb 13, 2020
FY2018 Dec 31, 2016 $23.22B Feb 14, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.07B Feb 12, 2026
FY2025 Dec 31, 2024 $4.23B Feb 12, 2026
FY2024 Dec 31, 2023 $3.98B Feb 13, 2025
FY2023 Dec 31, 2022 $3.95B Feb 15, 2024
FY2022 Dec 31, 2021 $4.01B Feb 16, 2023
FY2021 Dec 31, 2020 $3.98B Feb 17, 2022
FY2020 Dec 31, 2019 $3.96B Feb 11, 2021
FY2019 Dec 31, 2018 $3.94B Feb 13, 2020
FY2018 Dec 31, 2017 $3.95B Feb 14, 2019
FY2017 Dec 31, 2016 $3.58B Feb 15, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $54.93B Feb 12, 2026
FY2025 Dec 31, 2024 $49.63B Feb 12, 2026
FY2024 Dec 31, 2023 $45.59B Feb 13, 2025
FY2023 Dec 31, 2022 $43.52B Feb 15, 2024
FY2022 Dec 31, 2021 $41.56B Feb 16, 2023
FY2021 Dec 31, 2020 $38.77B Feb 17, 2022
FY2020 Dec 31, 2019 $36.98B Feb 11, 2021
FY2019 Dec 31, 2018 $35.20B Feb 13, 2020
FY2018 Dec 31, 2017 $33.46B Feb 14, 2019
FY2017 Dec 31, 2016 $32.20B Feb 15, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 27 Feb 12, 2026
FY2025 Dec 31, 2024 21 Feb 12, 2026
FY2025 Dec 31, 2023 12 Feb 12, 2026
FY2024 Dec 31, 2022 11 Feb 13, 2025
FY2023 Dec 31, 2021 14 Feb 15, 2024
FY2020 Dec 31, 2020 5 Feb 11, 2021
FY2020 Sep 30, 2020 3 Feb 11, 2021
FY2020 Jun 30, 2020 0 Feb 11, 2021
FY2020 Mar 31, 2020 2 Feb 11, 2021
FY2020 Dec 31, 2019 3 Feb 11, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 27 Feb 12, 2026
FY2025 Dec 31, 2024 21 Feb 12, 2026
FY2025 Dec 31, 2023 12 Feb 12, 2026
FY2024 Dec 31, 2022 11 Feb 13, 2025
FY2023 Dec 31, 2021 14 Feb 15, 2024
FY2020 Dec 31, 2020 5 Feb 11, 2021
FY2020 Sep 30, 2020 3 Feb 11, 2021
FY2020 Jun 30, 2020 0 Feb 11, 2021
FY2020 Mar 31, 2020 2 Feb 11, 2021
FY2020 Dec 31, 2019 3 Feb 11, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 217.50M Feb 12, 2026
FY2025 Dec 31, 2024 226.60M Feb 12, 2026
FY2024 Dec 31, 2023 228.20M Feb 13, 2025
FY2023 Dec 31, 2022 232.10M Feb 15, 2024
FY2022 Dec 31, 2021 241.20M Feb 16, 2023
FY2021 Dec 31, 2020 252.40M Feb 17, 2022
FY2020 Dec 31, 2019 255.50M Feb 11, 2021
FY2019 Dec 31, 2018 263.60M Feb 13, 2020
FY2018 Dec 31, 2017 271.40M Feb 14, 2019
FY2017 Dec 31, 2016 279.60M Feb 15, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $979.00M Feb 12, 2026
FY2025 Dec 31, 2024 $951.00M Feb 12, 2026
FY2025 Dec 31, 2023 $908.00M Feb 12, 2026
FY2024 Dec 31, 2022 $875.00M Feb 13, 2025
FY2023 Dec 31, 2021 $869.00M Feb 15, 2024
FY2022 Dec 31, 2020 $861.00M Feb 16, 2023
FY2021 Dec 31, 2019 $844.00M Feb 17, 2022
FY2020 Dec 31, 2018 $814.00M Feb 11, 2021
FY2019 Dec 31, 2017 $785.00M Feb 13, 2020
FY2018 Dec 31, 2016 $757.00M Feb 14, 2019